56 results
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Feb 24
Current report (foreign)
4:50pm
of 1933, as amended. The Board has determined that Mr. Huang is an independent director in accordance with the listing requirements of The Nasdaq Stock
6-K
EX-99.1
xakwddiamvr fd3
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.1
2ctueg9n
5 Jun 23
Current report (foreign)
4:28pm
S-8
EX-23.1
tdjs5kf4cl09mfdcue
1 Jul 22
Registration of securities for employees
5:12pm
F-3/A
ojitcci7z62 1053
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
EX-23.2
05kh xozgn
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
EX-99.1
tihchtn4
10 Jun 22
Current report (foreign)
6:05am
F-3/A
qb7cixkv4
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3/A
EX-23.2
9wc cy7j0r
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
EX-99.2
gpm4wmya1
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
F-3
EX-1.2
t4mf2qjbg5l8mo
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-23.2
6y9yaz emo9
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
lzmfebcif9lmdw
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
5858 belwyt4s88ppv3
31 Mar 22
Annual report (foreign)
4:33pm